Security Snapshot

Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) Institutional Ownership

CUSIP: 03168L105

13F Institutional Holders and Ownership History from Q2 2018 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

239

Shares (Excl. Options)

109.06MFull value: 109,058,387 · shares · 30 Sep 2026

Price

$20.14

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+2,855,424
Value change
+$72,412,333
Number of holders
239
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
348,532,261
SEC-reported price per share
$19.25
Insider filing price
$19.25
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 is tracked under CUSIP 03168L105.
  • 239 institutions reported positions in Q3 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 309 to 239 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $2.82BFull value: $2,822,870,668 · USD · 30 Jun 2026
    to
    $2.2BFull value: $2,195,956,567 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 239 institutions filings for Q3 2026.

Open SEC evidence

Security key

03168L105

13F reference period

Q3 2026

13F holders

239

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
AMRX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Patel Tushar Bhikhubhai 18% +12% $1,061,824,446 +$220,935,648 61,341,678 +26% Tushar Patel 10 Aug 2026
Patel Chintu 9.4% +15% $563,899,700 +$115,397,046 32,576,528 +26% Chintu Patel 10 Aug 2026
Patel Chirag K. 8.4% +19% $503,680,235 +$119,737,147 29,097,645 +31% Chirag Patel 10 Aug 2026
Mahesh Akram 6.6% $153,779,517 20,558,759 Akram Mahesh 31 Mar 2025
Patel Dipan 5.4% -28% $244,942,771 -$100,339,323 16,904,263 -29% Patel Dipan 31 Dec 2025
VANGUARD GROUP INC 5% $117,905,198 15,762,727 The Vanguard Group 31 Mar 2025
As of 30 Sep 2026, 239 institutional investors reported holding
109.06MFull value: 109,058,387 · shares · 30 Sep 2026
shares of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX). This represents 31% of the company’s total
348.53MFull value: 348,532,261 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
25%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD PORTFOLIO MANAGEMENT LLC 3.5% 12,365,663 0.01% $249,044,453
TPG GP A, LLC 3.5% 12,328,767 6% $248,301,367
Rubric Capital Management LP 2.4% 8,536,755 1.6% $171,930,246
VANGUARD CAPITAL MANAGEMENT LLC 2.3% 7,987,664 0% $160,871,553
STATE STREET CORP 2.1% 7,471,033 0% $150,466,605
Invesco Ltd. 1.7% 5,965,042 0.01% $120,135,946
DIMENSIONAL FUND ADVISORS LP 1.7% 5,816,123 0.02% $117,138,358
GEODE CAPITAL MANAGEMENT, LLC 1.3% 4,568,902 0% $92,034,830
NEUBERGER BERMAN GROUP LLC 0.96% 3,350,096 0.05% $67,480,515
GOLDMAN SACHS GROUP INC 0.74% 2,595,553 0.01% $52,274,437
Tri Locum Partners LP 0.67% 2,326,733 9.3% $46,860,403
Nantahala Capital Management, LLC 0.61% 2,115,749 2.4% $42,611,185
Assenagon Asset Management S.A. 0.58% 2,026,781 0.04% $40,819,369
CONGRESS ASSET MANAGEMENT CO 0.44% 1,524,355 0.2% $30,700,510
VANGUARD FIDUCIARY TRUST CO 0.35% 1,228,472 0.01% $24,741,426
Public Sector Pension Investment Board 0.29% 1,026,235 0.04% $20,032,107
RAYMOND JAMES FINANCIAL INC 0.25% 874,367 0% $17,609,752
PFM Health Sciences, LP 0.24% 822,891 1.8% $16,573,025
PANAGORA ASSET MANAGEMENT INC 0.23% 790,578 0.05% $15,922,241
BANK OF AMERICA CORP /DE/ 0.22% 779,565 0% $15,700,438
Soleus Capital Management, L.P. 0.19% 658,000 0.47% $13,252,120
Pictet Asset Management Holding SA 0.18% 638,040 0.01% $12,887,031
TUCKER ASSET MANAGEMENT LLC 0.15% 511,064 2.5% $10,292,829
Woodline Partners LP 0.14% 482,264 0.03% $9,712,797
Voleon Capital Management LP 0.13% 464,452 0.17% $9,354,063

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
34
Headline period
Q3 2026
Rows shown
1-25 of 34
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 109,058,387 $2,195,956,567 +$72,412,333 $20.14 239
2026 Q2 163,257,961 $2,822,870,668 +$58,643,983 $17.31 309
2026 Q1 160,913,103 $1,999,941,708 +$45,928,813 $12.43 317
2025 Q4 154,615,634 $1,947,916,977 +$47,523,787 $12.60 278
2025 Q3 150,638,837 $1,508,259,054 +$80,688,644 $10.01 243
2025 Q2 141,656,835 $1,146,033,099 +$54,531,142 $8.09 237
2025 Q1 134,631,456 $1,128,246,067 +$84,513,755 $8.38 232
2024 Q4 125,924,024 $997,296,789 -$136,424,861 $7.92 194
2024 Q3 142,604,811 $1,186,537,394 +$32,304,784 $8.32 180
2024 Q2 138,637,695 $880,361,225 +$192,128,358 $6.35 179
2024 Q1 108,100,411 $655,086,509 -$6,545,489 $6.06 173
2023 Q4 109,241,884 $663,112,026 +$52,701,039 $6.07 151
2023 Q3 101,896,343 $430,042,448 +$19,693,333 $4.22 141
2023 Q2 97,368,877 $301,754,419 +$4,221,215 $3.10 122
2023 Q1 96,883,833 $134,657,443 -$8,205,387 $1.39 142
2022 Q4 101,876,885 $202,739,453 +$4,463,674 $1.99 155
2022 Q3 99,522,767 $201,053,119 -$1,681,376 $2.02 144
2022 Q2 99,362,374 $315,991,849 -$2,095,558 $3.18 140
2022 Q1 100,125,536 $417,146,539 -$2,779,055 $4.17 154
2021 Q4 100,743,592 $481,044,810 -$750,941 $4.79 148
2021 Q3 100,372,906 $535,260,080 +$2,515,423 $5.34 150
2021 Q2 99,933,342 $511,565,477 -$13,076,955 $5.12 153
2021 Q1 101,580,612 $683,525,934 +$24,752,974 $6.73 155
2020 Q4 99,489,363 $454,601,386 -$9,010,325 $4.57 128
2020 Q3 101,459,246 $393,634,017 -$1,370,007 $3.88 133
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .